P&G Portfolio Trimming ‘Full Steam Ahead’ As Currency Headwind Pummels Profit
This article was originally published in The Tan Sheet
P&G’s net income declined 31% in its second quarter and will decline for its full fiscal 2015 due to foreign exchange, but the firm remains focused on core brand growth and innovation and will weather the storm. The company so far sold or consolidated 35 of the 90 to 100 brands on its streamlining chopping block.
You may also be interested in...
Marketing exclusivity would be a key advantage as Nexium 24HR enters a crowded market of branded and private label OTC competitors. The NDA for Nexium 24HR included clinical data, Pfizer says, but whether FDA allowed Hatch-Waxman Act exclusivity for the product is not yet determined.
The US Federal Trade Commission is "fully prepared" to bring forward cases after issuing hundreds of penalty offense notices in April regarding health claims substantiation, and it is likely to seek injunctive and monetary relief, said Samuel Levine, director of the FTC’s Bureau of Consumer Protection, at the National Advertising Division’s annual conference in Philadelphia.
The US FTC’s Sam Levine, director of the Bureau of Consumer Protection, discusses the advent of AI and the compounding risks consumers face in today’s evolving, largely unregulated, profoundly uncertain digital age.